TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10953934
log Bayes Factor = 5.13644
Chromosome 7   position 120,901,695  (GRCh37) Explore rs10953934 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
S52.50 Fracture of lower end of radius (closed)
0.000 0.000 1.000
S52.60 Fracture of lower end of both ulna and radius (closed)
0.000 0.002 0.998
S52.5 Fracture of lower end of radius
0.000 0.017 0.983
S52.6 Fracture of lower end of both ulna and radius
0.000 0.017 0.983
S52 Fracture of forearm
0.000 0.025 0.975
S52.9 Fracture of forearm, part unspecified
0.000 0.301 0.699
S52.8 Fracture of other parts of forearm
0.000 0.316 0.683
S52.1 Fracture of upper end of radius
0.000 0.370 0.630
S52.61 Fracture of lower end of both ulna and radius (open)
0.000 0.385 0.615
S52.51 Fracture of lower end of radius (open)
0.000 0.400 0.600
S52.7 Multiple fractures of forearm
0.000 0.401 0.599
S52.4 Fracture of shafts of both ulna and radius
0.000 0.434 0.565
S52.3 Fracture of shaft of radius
0.000 0.435 0.565
S52.0 Fracture of upper end of ulna
0.000 0.441 0.559
S52.91 Fracture of forearm, part unspecified (open)
0.000 0.499 0.501
S52.90 Fracture of forearm, part unspecified (closed)
0.000 0.499 0.501
S52.81 Fracture of other parts of forearm (open)
0.000 0.510 0.490
S52.80 Fracture of other parts of forearm (closed)
0.000 0.525 0.474
S52.2 Fracture of shaft of ulna
0.001 0.560 0.439
S52.11 Fracture of upper end of radius (open)
0.000 0.562 0.438
S52.71 Multiple fractures of forearm (open)
0.000 0.570 0.430
S52.31 Fracture of shaft of radius (open)
0.000 0.595 0.405
S52.10 Fracture of upper end of radius (closed)
0.000 0.599 0.401
S52.41 Fracture of shafts of both ulna and radius (open)
0.000 0.624 0.375
S52.01 Fracture of upper end of ulna (open)
0.000 0.642 0.358
S52.70 Multiple fractures of forearm (closed)
0.000 0.670 0.330
S52.00 Fracture of upper end of ulna (closed)
0.000 0.675 0.325
S52.40 Fracture of shafts of both ulna and radius (closed)
0.000 0.682 0.318
S52.21 Fracture of shaft of ulna (open)
0.001 0.718 0.281
S52.30 Fracture of shaft of radius (closed)
0.001 0.729 0.270
S52.20 Fracture of shaft of ulna (closed)
0.002 0.859 0.139
S50-S59 Injuries to the elbow and forearm
0.000 0.895 0.105
S58 Traumatic amputation of forearm
0.000 0.924 0.076
S57 Crushing injury of forearm
0.000 0.924 0.076
S55 Injury of blood vessels at forearm level
0.000 0.925 0.075
S56 Injury of muscle and tendon at forearm level
0.000 0.926 0.074
I70.20 Atherosclerosis of arteries of extremities (without gangrene)
0.000 0.929 0.071
S59 Other and unspecified injuries of forearm
0.000 0.930 0.070
S51 Open wound of forearm
0.000 0.931 0.069
S56.3 Injury of extensor or abductor muscles and tendons of thumb at forearm level
0.000 0.937 0.063
S53 Dislocation, sprain and strain of joints and ligaments of elbow
0.000 0.939 0.061
S51.8 Open wound of other parts of forearm
0.000 0.941 0.059
S54 Injury of nerves at forearm level
0.000 0.942 0.058
S55.1 Injury of radial artery at forearm level
0.000 0.942 0.058
S50 Superficial injury of forearm
0.000 0.942 0.057
I70.2 Atherosclerosis of arteries of the extremities
0.000 0.945 0.055
S56.8 Injury of other and unspecified muscles and tendons at forearm level
0.000 0.945 0.055
S57.9 Crushing injury of forearm, part unspecified
0.000 0.945 0.054
S57.8 Crushing injury of forearm, part unspecified
0.000 0.945 0.054
S57.7 Crushing injury of other parts of forearm
0.000 0.945 0.054
S57.0 Crushing injury of elbow
0.000 0.945 0.054
S58.9 Traumatic amputation of forearm, level unspecified
0.000 0.945 0.054
S58.1 Traumatic amputation at level between elbow and wrist
0.000 0.945 0.054
S58.0 Traumatic amputation at elbow level
0.000 0.945 0.054
S55.9 Injury of unspecified blood vessel at forearm level
0.000 0.946 0.054
S55.8 Injury of other blood vessels at forearm level
0.000 0.946 0.054
S55.7 Injury of multiple blood vessels at forearm level
0.000 0.946 0.054
S55.2 Injury of vein at forearm level
0.000 0.946 0.054
S56.2 Injury of other flexor muscle and tendon at forearm level
0.000 0.947 0.053
S56.0 Injury of flexor muscle and tendon of thumb at forearm level
0.000 0.947 0.053
S56.1 Injury of flexor muscle and tendon of other finger(s) at forearm level
0.000 0.948 0.052
S56.7 Injury of multiple muscles and tendons at forearm level
0.000 0.949 0.051
S59.8 Other specified injuries of forearm
0.000 0.950 0.050
S59.7 Multiple injuries of forearm
0.000 0.950 0.050
S51.9 Open wound of forearm, part unspecified
0.000 0.951 0.049
S55.0 Injury of ulnar artery at forearm level
0.000 0.952 0.047
S56.4 Injury of extensor muscle and tendon of other finger(s) at forearm level
0.000 0.952 0.047
S50.8 Other superficial injuries of forearm
0.000 0.953 0.047
I70.21 Atherosclerosis of arteries of extremities (with gangrene)
0.000 0.954 0.046
S59.9 Unspecified injury of forearm
0.000 0.955 0.044
S53.2 Traumatic rupture of radial collateral ligament
0.000 0.956 0.044
S53.1 Dislocation of elbow, unspecified
0.000 0.956 0.044
S53.3 Traumatic rupture of ulnar collateral ligament
0.000 0.957 0.043
S51.0 Open wound of elbow
0.000 0.958 0.042
S56.5 Injury of other extensor muscle and tendon at forearm level
0.000 0.958 0.042
S54.2 Injury of radial nerve at forearm level
0.000 0.958 0.042
S54.9 Injury of unspecified nerve at forearm level
0.000 0.958 0.042
S54.8 Injury of other nerves at forearm level
0.000 0.958 0.042
S54.7 Injury of multiple nerves at forearm level
0.000 0.958 0.042
S54.3 Injury of cutaneous sensory nerve at forearm level
0.000 0.958 0.042
S50.1 Contusion of other and unspecified parts of forearm
0.000 0.959 0.041
S54.1 Injury of median nerve at forearm level
0.000 0.959 0.040
S50.7 Multiple superficial injuries of forearm
0.000 0.960 0.040
S53.4 Sprain and strain of elbow
0.000 0.961 0.038
S56.20 Unspecified injury of other flexor muscle, fascia and tendon at forearm level
0.000 0.962 0.038
S53.0 Dislocation of radial head
0.000 0.963 0.037
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.963 0.037
I70 Atherosclerosis
0.000 0.964 0.036
S51.7 Multiple open wounds of forearm
0.000 0.964 0.036
S50.0 Contusion of elbow
0.000 0.967 0.033
I70.1 Atherosclerosis of renal artery
0.000 0.968 0.032
S53.11 Anterior subluxation and dislocation of ulnohumeral joint
0.000 0.968 0.031
S53.10 Unspecified subluxation and dislocation of ulnohumeral joint
0.000 0.968 0.031
S54.20 Injury of radial nerve at forearm level, unspecified arm
0.000 0.970 0.030
C85.1 B-cell lymphoma, unspecified
0.000 0.970 0.030
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.970 0.030
Y43.3 Other antineoplastic drugs
0.000 0.970 0.030
I70.10 Atherosclerosis of renal artery (without gangrene)
0.000 0.971 0.028
I70.9 Generalised and unspecified atherosclerosis
0.000 0.972 0.028
I70.0 Atherosclerosis of aorta
0.000 0.973 0.027
S54.0 Injury of ulnar nerve at forearm level
0.001 0.973 0.027
S50.9 Superficial injury of forearm, unspecified
0.000 0.974 0.026
Y43 Primarily systemic agents
0.000 0.974 0.026
I70.8 Atherosclerosis of other arteries
0.000 0.975 0.025
Y52 Agents primarily affecting the cardiovascular system
0.000 0.975 0.025
L30.9 Dermatitis, unspecified
0.024 0.976 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.976 0.024
Y52.1 Calcium-channel blockers
0.000 0.977 0.023
I70.11 Atherosclerosis of renal artery (with gangrene)
0.000 0.977 0.023
Y43.1 Antineoplastic antimetabolites
0.000 0.977 0.023
I70.90 Generalized and unspecified atherosclerosis (without gangrene)
0.000 0.977 0.023
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.978 0.022
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.978 0.022
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.978 0.022
C85.0 Lymphosarcoma
0.000 0.978 0.022
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.000 0.978 0.022
I70.00 Atherosclerosis of aorta (without gangrene)
0.000 0.979 0.021
I70.91 Generalized and unspecified atherosclerosis (with gangrene)
0.000 0.979 0.020
I70.01 Atherosclerosis of aorta (with gangrene)
0.000 0.980 0.020
Y52.4 Angiotensin-converting-enzyme inhibitors
0.000 0.980 0.020
Y43.0 Antiallergic and antiemetic drugs
0.000 0.980 0.020
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.000 0.981 0.019
Y43.9 Primarily systemic agent, unspecified
0.000 0.981 0.019
Y43.8 Other primarily systemic agents, not elsewhere classified
0.000 0.981 0.019
Y43.6 Enzymes, not elsewhere classified
0.000 0.981 0.019
Y43.5 Acidifying and alkalising agents
0.000 0.981 0.019
Y43.2 Antineoplastic natural products
0.000 0.981 0.019
Y59 Other and unspecified vaccines and biological substances
0.000 0.981 0.019
I70.81 Atherosclerosis of other arteries (with gangrene)
0.000 0.981 0.018
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.982 0.018
Y52.8 Antivaricose drugs, including sclerosing agents
0.000 0.982 0.018
Y52.7 Peripheral vasodilators
0.000 0.982 0.018
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.982 0.018
Y48 Anaesthetics and therapeutic gases
0.000 0.982 0.018
I70.80 Atherosclerosis of other arteries (without gangrene)
0.000 0.982 0.017
Y51 Drugs primarily affecting the autonomic nervous system
0.000 0.983 0.017
S62.60 Fracture of other finger (closed)
0.000 0.983 0.017
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.000 0.983 0.017
Y59.3 Immunoglobulin
0.000 0.983 0.016
Y54.3 Benzothiadiazine derivatives
0.000 0.984 0.016
Y48.3 Local anaesthetics
0.000 0.984 0.016
Y58 Bacterial vaccines
0.000 0.984 0.016
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.984 0.016
Y50 Central nervous system stimulants, not elsewhere classified
0.000 0.984 0.016
Y49 Psychotropic drugs, not elsewhere classified
0.000 0.984 0.016
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.000 0.984 0.016
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.985 0.015
Y54.5 Other diuretics
0.000 0.985 0.015
Y46 Antiepileptics and anti-Parkinsonism drugs
0.000 0.985 0.015
Y54.8 Agents affecting uric acid metabolism
0.000 0.985 0.015
Y53 Agents primarily affecting the gastro-intestinal system
0.000 0.985 0.014
Y47 Sedatives, hypnotics and antianxiety drugs
0.000 0.985 0.014
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.000 0.985 0.014
K42.9 Umbilical hernia without obstruction or gangrene
0.000 0.986 0.014
Y45.2 Propionic acid derivatives
0.000 0.986 0.014
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.986 0.014
Y48.2 Other and unspecified general anaesthetics
0.000 0.986 0.014
Y42.0 Glucocorticoids and synthetic analogs
0.000 0.986 0.014
Y54.9 Mineral salts, not elsewhere classified
0.000 0.986 0.014
Y54.6 Electrolytic, caloric and water-balance agents
0.000 0.986 0.014
Y54.2 Carbonic-anhydrase inhibitors
0.000 0.986 0.014
Y54.0 Mineralocorticoids
0.000 0.986 0.014
Y45.1 Salicylates
0.000 0.986 0.014
Y54.7 Agents affecting calcification
0.000 0.986 0.014
Y54.4 Loop [high-ceiling] diuretics
0.000 0.986 0.014
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.986 0.014
Y59.9 Vaccine or biological substance, unspecified
0.000 0.986 0.013
Y59.8 Other specified vaccines and biological substances
0.000 0.986 0.013
Y59.2 Protozoal vaccines
0.000 0.986 0.013
Y59.1 Rickettsial vaccines
0.000 0.986 0.013
Y59.0 Viral vaccines
0.000 0.986 0.013
S00.8 Superficial injury of other parts of head
0.000 0.986 0.014
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.986 0.013
Y45.0 Opioids and related analgesics
0.000 0.987 0.013
Y48.5 Therapeutic gases
0.000 0.987 0.013
Y48.1 Parenteral anaesthetics
0.000 0.987 0.013
Y48.0 Inhaled anaesthetics
0.000 0.987 0.013
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.000 0.987 0.013
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.987 0.013
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.987 0.013
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.987 0.013
Y51.1 Other parasympathomimetics [cholinergics]
0.000 0.987 0.013
Y51.0 Anticholinesterase agents
0.000 0.987 0.013
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.987 0.013
Y43.4 Immunosuppressive agents
0.000 0.987 0.012
D70 Agranulocytosis
0.000 0.988 0.012
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.988 0.012
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.988 0.012
Y49.5 Other antipsychotics and neuroleptics
0.000 0.988 0.012
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.988 0.012
Y45.4 Antirheumatics
0.000 0.988 0.012
Y42.2 Antithyroid drugs
0.000 0.988 0.012
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.988 0.012
Y58.0 BCG vaccine
0.000 0.988 0.012
Y49.2 Other and unspecified antidepressants
0.000 0.988 0.012
Y46.2 Hydantoin derivatives
0.000 0.988 0.012
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.988 0.012
Y56.3 Emollients, demulcents and protectants
0.000 0.988 0.012
Y58.9 Other and unspecified bacterial vaccines
0.000 0.988 0.012
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.000 0.988 0.012
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.000 0.988 0.012
Y58.5 Diphtheria vaccine
0.000 0.988 0.012
Y58.4 Tetanus vaccine
0.000 0.988 0.012
Y58.3 Plague vaccine
0.000 0.988 0.012
Y58.2 Cholera vaccine
0.000 0.988 0.012
Y58.1 Typhoid and paratyphoid vaccine
0.000 0.988 0.012
Y42.1 Thyroid hormones and substitutes
0.000 0.988 0.012
Y57 Other and unspecified drugs and medicaments
0.000 0.988 0.012
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.988 0.012
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.000 0.988 0.011
Y50.9 Central nervous system stimulant, unspecified
0.000 0.988 0.011
Y50.8 Other central nervous system stimulants
0.000 0.988 0.011
Y50.2 Methylxanthines, not elsewhere classified
0.000 0.988 0.011
Y50.1 Opioid receptor antagonists
0.000 0.988 0.011
Y50.0 Analeptics
0.000 0.988 0.011
Y49.9 Psychotropic drug, unspecified
0.000 0.988 0.011
Y49.8 Other psychotropic drugs, not elsewhere classified
0.000 0.988 0.011
Y49.7 Psychostimulants with abuse potential
0.000 0.988 0.011
Y49.6 Psychodysleptics [hallucinogens]
0.000 0.988 0.011
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.988 0.011
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.988 0.011
Y56.9 Topical agent, unspecified
0.000 0.988 0.011
Y56.8 Other topical agents
0.000 0.988 0.011
Y56.7 Dental drugs, topically applied
0.000 0.988 0.011
Y56.6 Otorhinolaryngological drugs and preparations
0.000 0.988 0.011
Y56.5 Ophthalmological drugs and preparations
0.000 0.988 0.011
Y56.2 Local astringents and local detergents
0.000 0.988 0.011
Y56.1 Antipruritics
0.000 0.988 0.011
C88 Malignant immunoproliferative diseases
0.000 0.988 0.011
Y49.0 Tricyclic and tetracyclic antidepressants
0.000 0.989 0.011
Y42.9 Other and unspecified hormone antagonists
0.000 0.989 0.011
C81 Hodgkin's disease
0.000 0.989 0.011
Y45.8 Other analgesics and antipyretics
0.000 0.989 0.011
Y42.7 Androgens and anabolic congeners
0.000 0.989 0.011
Y46.8 Antispasticity drugs
0.000 0.989 0.011
Y46.3 Deoxybarbiturates
0.000 0.989 0.011
Y46.1 Oxazolidinediones
0.000 0.989 0.011
Y46.0 Succinimides
0.000 0.989 0.011
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.000 0.989 0.011
Y46.4 Iminostilbenes
0.000 0.989 0.011
Y46.7 Anti-Parkinsonism drugs
0.000 0.989 0.011
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.000 0.989 0.010
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.000 0.989 0.010
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.000 0.989 0.010
Y47.4 Bromine compounds
0.000 0.989 0.010
Y47.3 Paraldehyde
0.000 0.989 0.010
Y47.2 Chloral derivatives
0.000 0.989 0.010
Y47.0 Barbiturates, not elsewhere classified
0.000 0.989 0.010
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.989 0.011
Y53.7 Emetics
0.000 0.989 0.011
Y53.6 Antidiarrhoeal drugs
0.000 0.989 0.011
Y53.5 Digestants
0.000 0.989 0.011
Y53.3 Saline and osmotic laxatives
0.000 0.989 0.011
Y53.2 Stimulant laxatives
0.000 0.989 0.011
Y53.0 Histamine H2-receptor antagonists
0.000 0.989 0.011
Y46.5 Valproic acid
0.000 0.989 0.010
Y42.4 Oral contraceptives
0.000 0.989 0.010
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.989 0.010
Y53.1 Other antacids and anti-gastric-secretion drugs
0.000 0.990 0.010
Y46.6 Other and unspecified antiepileptics
0.000 0.990 0.010
Y55.6 Antiasthmatics, not elsewhere classified
0.000 0.990 0.010
K42 Umbilical hernia
0.000 0.990 0.010
Y53.4 Other laxatives
0.000 0.990 0.010
C84.5 Other and unspecified T-cell lymphomas
0.000 0.990 0.010
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.990 0.010
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.990 0.010
C84.4 Peripheral T-cell lymphoma
0.000 0.990 0.010
Y44 Agents primarily affecting blood constituents
0.000 0.990 0.010
K42.0 Umbilical hernia with obstruction, without gangrene
0.000 0.990 0.010
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.990 0.010
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.990 0.010
Y55.5 Anticommon cold drugs
0.000 0.990 0.010
Y55.3 Antitussives
0.000 0.990 0.010
Y55.2 Other and unspecified agents primarily acting on muscles
0.000 0.990 0.010
Y55.0 Oxytocic drugs
0.000 0.990 0.010
Y41 Other systemic anti-infectives and antiparasitics
0.000 0.990 0.009
S00.2 Other superficial injuries of eyelid and periocular area
0.000 0.990 0.010
C81.0 Lymphocytic predominance
0.000 0.990 0.010
C93 Monocytic leukaemia
0.000 0.990 0.010
Y47.1 Benzodiazepines
0.000 0.990 0.009
S00 Superficial injury of head
0.000 0.990 0.010
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.991 0.009
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.991 0.009
C94 Other leukaemias of specified cell type
0.000 0.991 0.009
C84.0 Mycosis fungoides
0.000 0.991 0.009
M21.57 Acquired clawhand, clubhand, clawfoot and clubfoot (Ankle and foot)
0.009 0.991 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.991 0.009
M21.06 Valgus deformity, not elsewhere classified (Lower leg)
0.009 0.991 0.000
C81.9 Hodgkin's disease, unspecified
0.000 0.991 0.009
C95 Leukaemia of unspecified cell type
0.000 0.991 0.009
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.000 0.991 0.009
Y57.8 Other drugs and medicaments
0.000 0.991 0.009
Y55.4 Expectorants
0.000 0.991 0.008
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.991 0.009
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.991 0.009
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.991 0.009
C84.3 Lymphoepithelioid lymphoma
0.000 0.991 0.009
C84.2 T-zone lymphoma
0.000 0.991 0.009
C84.1 Sezary's diease
0.000 0.991 0.009
C81.1 Nodular sclerosis
0.000 0.991 0.009
M54.36 Sciatica (Lumbar region)
0.009 0.991 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.000 0.991 0.008
Y57.7 Vitamins, not elsewhere classified
0.000 0.991 0.008
Y57.4 Pharmaceutical excipients
0.000 0.991 0.008
Y57.3 Alcohol deterrents
0.000 0.991 0.008
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.000 0.991 0.008
Y57.1 Lipotropic drugs
0.000 0.991 0.008
Y57.0 Appetite depressants [anorectics]
0.000 0.991 0.008
C86 Other specified types of T/NK-cell lymphoma
0.000 0.991 0.008
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.991 0.008
C81.7 Other Hodgkin's disease
0.000 0.991 0.008
S62.6 Fracture of other finger
0.000 0.991 0.009
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.991 0.008
C88.7 Other malignant immunoproliferative diseases
0.000 0.991 0.008
C88.3 Immunoproliferative small intestinal disease
0.000 0.991 0.008
C88.2 Gamma heavy chain disease
0.000 0.991 0.008
C88.1 Alpha heavy chain disease
0.000 0.991 0.008
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.992 0.008
Y45.5 4-Aminophenol derivatives
0.000 0.992 0.008
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.992 0.008
C81.3 Lymphocytic depletion
0.000 0.992 0.008
Y48.4 Anaesthetic, unspecified
0.001 0.992 0.008
S00.4 Superficial injury of ear
0.000 0.992 0.008
T79.6 Traumatic ischaemia of muscle
0.000 0.992 0.008
Y57.5 X-ray contrast media
0.000 0.992 0.008
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.000 0.992 0.008
Q21.1 Atrial septal defect
0.008 0.992 0.000
Y40 Systemic antibiotics
0.000 0.992 0.008
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.992 0.008
C90 Multiple myeloma and malignant plasma cell neoplasms
0.000 0.992 0.008
S00.7 Multiple superficial injuries of head
0.000 0.992 0.008
C92 Myeloid leukaemia
0.000 0.992 0.008
Y41.1 Antimycobacterial drugs
0.000 0.992 0.008
M21.0 Valgus deformity, not elsewhere classified
0.008 0.992 0.000
Y41.0 Sulphonamides
0.000 0.992 0.007
C81.2 Mixed cellularity
0.000 0.992 0.008
M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot
0.008 0.992 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.000 0.992 0.008
K42.1 Umbilical hernia with gangrene
0.000 0.992 0.008
Y44.9 Other and unspecified agents affecting blood constituents
0.000 0.992 0.007
Y44.7 Plasma substitutes
0.000 0.992 0.007
Y44.5 Thrombolytic drugs
0.000 0.992 0.007
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.000 0.992 0.007
S00.3 Superficial injury of nose
0.000 0.993 0.007
Y57.6 Other diagnostic agents
0.000 0.993 0.007
C93.1 Chronic monocytic leukaemia
0.000 0.993 0.007
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.993 0.007
Y41.4 Anthelminthics
0.000 0.993 0.007
Y41.3 Other antiprotozoal drugs
0.000 0.993 0.007
C95.0 Acute leukaemia of unspecified cell type
0.000 0.993 0.007
Y40.3 Macrolides
0.000 0.993 0.007
C83.1 Small cleaved cell (diffuse)
0.000 0.993 0.007
C93.9 Monocytic leukaemia, unspecified
0.000 0.993 0.007
C93.7 Other monocytic leukaemia
0.000 0.993 0.007
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.993 0.007
C93.2 Subacute monocytic leukaemia
0.000 0.993 0.007
C93.0 Acute monocytic leukaemia
0.000 0.993 0.007
Y44.6 Natural blood and blood products
0.000 0.993 0.007
C83.0 Small cell (diffuse)
0.000 0.993 0.007
L30 Other dermatitis
0.007 0.993 0.000
C83.7 Burkitt's tumour
0.000 0.993 0.007
C83.6 Undifferentiated (diffuse)
0.000 0.993 0.007
C83.5 Lymphoblastic (diffuse)
0.000 0.993 0.007
C83.4 Immunoblastic (diffuse)
0.000 0.993 0.007
C83.2 Mixed small and large cell (diffuse)
0.000 0.993 0.007
C94.7 Other specified leukaemias
0.000 0.993 0.007
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.993 0.007
C94.5 Acute myelofibrosis
0.000 0.993 0.007
C94.4 Acute panmyelosis
0.000 0.993 0.007
C94.3 Mast cell leukaemia
0.000 0.993 0.007
C94.2 Acute megakaryoblastic leukaemia
0.000 0.993 0.007
C94.1 Chronic erythraemia
0.000 0.993 0.007
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.993 0.007
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.993 0.007
C96.8 Histiocytic sarcoma
0.000 0.993 0.007
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.993 0.007
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.993 0.007
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.993 0.007
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.993 0.007
C96.3 True histiocytic lymphoma
0.000 0.993 0.007
C96.2 Malignant mast cell tumour
0.000 0.993 0.007
C96.1 Malignant histiocytosis
0.000 0.993 0.007
C96.0 Letterer-Siwe disease
0.000 0.993 0.007
S00.1 Contusion of eyelid and periocular area
0.000 0.993 0.007
C83.3 Large cell (diffuse)
0.000 0.993 0.007
C95.7 Other leukaemia of unspecified cell type
0.000 0.993 0.007
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.993 0.007
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.001 0.993 0.006
M21 Other acquired deformities of limbs
0.007 0.993 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.993 0.006
C92.4 Acute promyelocytic leukaemia
0.000 0.993 0.007
C95.9 Leukaemia, unspecified
0.000 0.993 0.006
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.994 0.006
C86.4 Blastic NK-cell lymphoma
0.000 0.994 0.006
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.994 0.006
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.994 0.006
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.994 0.006
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.994 0.006
S62.61 Fracture of other finger (open)
0.000 0.994 0.006
Y40.4 Tetracyclines
0.000 0.994 0.006
Z33 Pregnant state, incidental
0.006 0.994 0.000
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)
0.006 0.994 0.000
C90.2 Plasmacytoma, extramedullary
0.000 0.994 0.006
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.994 0.006
Y57.9 Drug or medicament, unspecified
0.000 0.994 0.006
S82.40 Fracture of fibula alone (closed)
0.000 0.994 0.006
Y40.2 Chloramphenicol group
0.000 0.994 0.006
E04.1 Non-toxic single thyroid nodule
0.006 0.994 0.000
Y41.5 Antiviral drugs
0.001 0.994 0.005
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.994 0.006
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.994 0.006
C92.5 Acute myelomonocytic leukaemia
0.000 0.994 0.006
C92.3 Myeloid sarcoma
0.000 0.994 0.006
C92.2 Subacute myeloid leukaemia
0.000 0.994 0.006
C92.9 Myeloid leukaemia, unspecified
0.000 0.994 0.006
C90.1 Plasma cell leukaemia
0.000 0.994 0.006
M21.09 Valgus deformity, not elsewhere classified (Site unspecified)
0.006 0.994 0.000
M21.08 Valgus deformity, not elsewhere classified (Other)
0.006 0.994 0.000
M21.05 Valgus deformity, not elsewhere classified (Pelvic region and thigh)
0.006 0.994 0.000
M21.04 Valgus deformity, not elsewhere classified (Hand)
0.006 0.994 0.000
M21.03 Valgus deformity, not elsewhere classified (Forearm)
0.006 0.994 0.000
M21.02 Valgus deformity, not elsewhere classified (Upper arm)
0.006 0.994 0.000
M21.01 Valgus deformity, not elsewhere classified (Shoulder region)
0.006 0.994 0.000
M21.00 Valgus deformity, not elsewhere classified (Multiple sites)
0.006 0.994 0.000
M21.6 Other acquired deformities of ankle and foot
0.006 0.994 0.000
Y40.0 Penicillins
0.000 0.994 0.006
M21.59 Acquired clawhand, clubhand, clawfoot and clubfoot-Site uns
0.006 0.994 0.000
M21.58 Acquired clawhand, clubhand, clawfoot and clubfoot-Other
0.006 0.994 0.000
M21.56 Acquired clawhand, clubhand, clawfoot and clubfoot-Lower le
0.006 0.994 0.000
M21.55 Acquired clawhand, clubhand, clawfoot and clubfoot-Pelvic/t
0.006 0.994 0.000
M21.54 Acquired clawhand, clubhand, clawfoot and clubfoot (Hand)
0.006 0.994 0.000
M21.53 Acquired clawhand, clubhand, clawfoot and clubfoot-Forearm
0.006 0.994 0.000
M21.52 Acquired clawhand, clubhand, clawfoot and clubfoot-Upper ar
0.006 0.994 0.000
M21.51 Acquired clawhand, clubhand, clawfoot and clubfoot-Shldr re
0.006 0.994 0.000
M21.50 Acquired clawhand, clubhand, clawfoot and clubfoot (Multiple sites)
0.006 0.994 0.000
C90.3 Solitary plasmacytoma
0.000 0.994 0.006
C92.1 Chronic myeloid leukaemia
0.000 0.994 0.006
Y40.6 Rifamycins
0.000 0.994 0.006
M21.1 Varus deformity, not elsewhere classified
0.006 0.994 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.994 0.005
S82.60 Fracture of lateral malleolus (closed)
0.000 0.994 0.006
L30.1 Dyshidrosis [pompholyx]
0.005 0.994 0.000
Y40.5 Aminoglycosides
0.000 0.994 0.005
S82.4 Fracture of fibula alone
0.000 0.994 0.005
T79 Certain early complications of trauma, not elsewhere classified
0.000 0.995 0.005
L30.0 Nummular dermatitis
0.005 0.995 0.000
S82.6 Fracture of lateral malleolus
0.000 0.995 0.005
S82.00 Fracture of patella (closed)
0.000 0.995 0.005
S00.0 Superficial injury of scalp
0.000 0.995 0.005
Y40.7 Antifungal antibiotics, systemically used
0.000 0.995 0.005
L30.5 Pityriasis alba
0.005 0.995 0.000
L30.2 Cutaneous autosensitisation
0.005 0.995 0.000
M21.67 Other acquired deformities of ankle and foot-Ankle/foot
0.005 0.995 0.000
S82.0 Fracture of patella
0.000 0.995 0.005
C92.7 Other myeloid leukaemia
0.000 0.995 0.005
M21.7 Unequal limb length (acquired)
0.005 0.995 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.995 0.005
S82 Fracture of lower leg, including ankle
0.000 0.995 0.005
M21.8 Other specified acquired deformities of limbs
0.005 0.995 0.000
S00.5 Superficial injury of lip and oral cavity
0.000 0.995 0.005
Y42.5 Other oestrogens and progestogens
0.000 0.995 0.005
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.995 0.005
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
0.000 0.995 0.005
S72.20 Subtrochanteric fracture (closed)
0.000 0.995 0.005
M21.9 Acquired deformity of limb, unspecified
0.005 0.995 0.000
T79.8 Other early complications of trauma
0.000 0.995 0.005
C90.0 Multiple myeloma
0.000 0.995 0.005
Y40.9 Systemic antibiotic, unspecified
0.000 0.995 0.005
M21.16 Varus deformity, not elsewhere classified (Lower leg)
0.005 0.995 0.000
L30.3 Infective dermatitis
0.005 0.995 0.000
M21.4 Flat foot [pes planus] (acquired)
0.005 0.995 0.000
S86 Injury of muscle and tendon at lower leg level
0.000 0.995 0.005
M21.2 Flexion deformity
0.005 0.995 0.000
C92.0 Acute myeloid leukaemia
0.000 0.995 0.005
T79.7 Traumatic subcutaneous emphysema
0.000 0.995 0.005
L30.8 Other specified dermatitis
0.004 0.995 0.000
M21.17 Varus deformity, not elsewhere classified (Ankle and foot)
0.004 0.995 0.000
M77.12 Lateral epicondylitis (Upper arm)
0.005 0.995 0.000
L30.4 Erythema intertrigo
0.004 0.995 0.000
Y40.8 Other systemic antibiotics
0.000 0.995 0.004
S82.61 Fracture of lateral malleolus (open)
0.000 0.995 0.004
M21.69 Other acquired deformities of ankle and foot-Site unspec
0.004 0.995 0.000
M21.68 Other acquired deformities of ankle and foot-Other
0.004 0.995 0.000
M21.66 Other acquired deformities of ankle and foot-Lower leg
0.004 0.995 0.000
M21.65 Other acquired deformities of ankle and foot-Pelvic/thigh
0.004 0.995 0.000
M21.64 Other acquired deformities of ankle and foot-Hand
0.004 0.995 0.000
M21.63 Other acquired deformities of ankle and foot-Forearm
0.004 0.995 0.000
M21.62 Other acquired deformities of ankle and foot-Upper arm
0.004 0.995 0.000
M21.61 Other acquired deformities of ankle and foot-Shldr region
0.004 0.995 0.000
M21.60 Other acquired deformities of ankle and foot-Mult sites
0.004 0.995 0.000
S86.1 Injury of other muscle(s) and tendon(s) of posterior muscle group at lower leg level
0.000 0.995 0.004
S82.01 Fracture of patella (open)
0.000 0.996 0.004
M21.75 Unequal limb length (acquired) (Pelvic region and thigh)
0.004 0.996 0.000
T79.5 Traumatic anuria
0.000 0.996 0.004
S82.7 Multiple fractures of lower leg
0.000 0.996 0.004
S86.8 Injury of other muscles and tendons at lower leg level
0.000 0.996 0.004
M21.19 Varus deformity, not elsewhere classified (Site unspecified)
0.004 0.996 0.000
M21.18 Varus deformity, not elsewhere classified (Other)
0.004 0.996 0.000
M21.15 Varus deformity, not elsewhere classified (Pelvic region and thigh)
0.004 0.996 0.000
M21.14 Varus deformity, not elsewhere classified (Hand)
0.004 0.996 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.